Also, quite a few properly proven adverse prognostic markers, such as U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their detrimental effect in people dealt with with VO. The one factor that remained predictive of a shorter progression-cost-free survival On this cohort of people was TP53 ab